London — Four-time Tour de France winner Chris Froome was cleared by cycling’s world governing body the International Cycling Union (UCI) on Monday of any wrongdoing after he tested positive for excessive levels of the asthma drug salbutamol and he is free to race in the 2018 event, which starts on Saturday. Froome, 33, had tested positive for excessive levels of salbutamol following a urine sample at September 2017’s Vuelta a Espana. The World Anti-Doping Agency (Wada) had informed the UCI it would accept, "based on the specific facts of the case", that Froome’s sample results "do not constitute an adverse analytical finding", the UCI said. "In light of Wada’s unparalleled access to information and authorship of the salbutamol regime, the UCI has decided … to close the proceedings against Mr Froome." The Briton had always denied any wrongdoing and has now been cleared to race in the Tour de France by the organisers who had attempted to prevent the rider from competing while under i...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.